Device
excimer light
excimer light is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
25%
Ph not_applicable
1
25%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
recruiting125%
unknown250%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_1
Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis
NCT06485505
completednot_applicable
Excimer Light in Psoriasis
NCT05283876
unknown
Excimer Light(308) Therapy for Resistant Alopecia Areata
NCT06149936
unknownphase_4
Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis
NCT04971239
Clinical Trials (4)
Showing 4 of 4 trials
NCT06485505Phase 1
Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis
NCT05283876Not Applicable
Excimer Light in Psoriasis
NCT06149936
Excimer Light(308) Therapy for Resistant Alopecia Areata
NCT04971239Phase 4
Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4